Cargando…

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome

Non-alcoholic fatty liver disease (NAFLD) is a common yet little recognized health problem in women with polycystic ovary syndrome (PCOS). In a retrospective setting, we investigated the effects of metformin treatment on the hepatic steatosis index (HSI) as a readily available biomarker panel for NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riemann, Annika, Blaschke, Martina, Jauho-Ghadimi, Annukka, Siggelkow, Heide, Gollisch, Katja Susanne Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331742/ https://www.ncbi.nlm.nih.gov/pubmed/35893386 http://dx.doi.org/10.3390/jcm11154294

Ejemplares similares

Hepatic steatosis in women with polycystic ovary syndrome
por: Hong, Xinyu, et al.
Publicado: (2023)

Prevalence of hepatic steatosis in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2013)

Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome
por: Jobira, Beza, et al.
Publicado: (2021)

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
por: Wang, Dongxu, et al.
Publicado: (2023)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
por: Al-Ruthia, Yazed Sulaiman, et al.
Publicado: (2017)

The Effect of Metformin Treatment on the Serum Levels of Homocysteine, Folic Acid, and Vitamin B12 in Patients with Polycystic Ovary Syndrome
por: Esmaeilzadeh, Sedigheh, et al.
Publicado: (2017)

Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
por: Chakraborty, Semanti, et al.
Publicado: (2020)

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients
por: Günday, Özlem Kayacık, et al.
Publicado: (2023)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome
por: Zhang, Jing, et al.
Publicado: (2017)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Crohn’s disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients’ disease stage and to bone mineral density()
por: Blaschke, Martina, et al.
Publicado: (2018)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With Clinical Symptoms Among Women With Polycystic Ovary Syndrome
por: Esmaeilzadeh, Seddigheh, et al.
Publicado: (2015)

The Effect of Short-term Treatment with Metformin on Insulin Resistance among Obese Iraqi Women with Polycystic Ovary Syndrome
por: Findakly, Sura Basil, et al.
Publicado: (2021)

Endoscopic intragastric balloon: a gimmick or a viable option for obesity?
por: Gollisch, Katja Susanne Claudia, et al.
Publicado: (2020)

Effects of obesity and 10 weeks metformin treatment on liver steatosis
por: Hakkak, Reza, et al.
Publicado: (2021)

Genetic Instability Promotes the Acquisition of Chromosomal Imbalances in T1b and T1c Breast Adenocarcinomas
por: Blegen, Harald, et al.
Publicado: (2001)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome
por: Zhang, Yuehui, et al.
Publicado: (2017)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
por: Li, Min, et al.
Publicado: (2017)

Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome
por: Zheng, Silan, et al.
Publicado: (2020)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Leptin and body mass index in polycystic ovary syndrome
por: Jalilian, Nasrin, et al.
Publicado: (2016)

Renal resistive index in patients with polycystic ovary syndrome
por: Tüfekçioğlu, Gülsen, et al.
Publicado: (2019)

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients
por: Shi, Wenjing, et al.
Publicado: (2021)

Insulin level, lipid profile, and HOMA index in lean and obese patients with polycystic ovary syndrome
por: Hussein, Shamim Riadh Mohammed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0vqv0jo4lm8vfq4aqth0gvsp5o